I-Geldanamycin CAS:30562-34-6

Nangona i-geldanamycin ibonakalise umsebenzi wokulwa nomhlaza kwizifundo zelebhu, ukusetyenziswa kwayo kwezonyango kulinganiselwe ngenxa yemingeni enxulumene nobuthi kunye nokuzinza. Imizamo yophando iyaqhubeka yokuphuhlisa ii-derivatives kunye nee-analogues ze-geldanamycin ezineempawu eziphuculweyo ze-pharmacokinetic kunye neziphumo ebezingalindelekanga ezincitshisiweyo kwizicelo zonyango ezinokubakho. Kwiimeko zovavanyo, i-geldanamycin kunye nee-derivatives zayo ziphandwe ngokukwazi kwayo ukuthintela umsebenzi we-Hsp90, okukhokelela ekonakaleni kweeproteni zabathengi ezibandakanyeka ekukhuleni nasekusindeni kweeseli zomhlaza. Le ndlela yenza i-geldanamycin ibe ngumviwa othembisayo kunyango lomhlaza olujoliswe kulo, ngakumbi kumhlaza oxhomekeke kwiindlela ezilawulwa yi-Hsp90. Uvavanyo lweklinikhi oluhlola ukusebenza kakuhle kunye nokhuseleko lwee-derivatives ze-geldanamycin kwizigulane zomhlaza luyaqhubeka ukuvavanya amandla azo njengeearhente zokulwa nomhlaza. Ezi zifundo zijolise ekuvavanyeni izibonelelo zonyango zeli yeza, iindlela ezifanelekileyo zokuthatha idosi, amazinga okuphendula, kunye nazo naziphi na iziphumo ezimbi ezinxulumene noko ukumisela ukusetyenziswa kwazo kwezonyango kwi-oncology. Intsebenziswano phakathi kwabaphandi, iinkampani zamayeza, ii-arhente zolawulo, kunye nababoneleli bezempilo kubalulekile ekuphuculeni uphuhliso lwezonyango ezisekelwe kwi-geldanamycin kunye nokuzisa unyango olutsha lokulwa nomhlaza kwizigulane eziludingayo. Uphando oluqhubekayo malunga neprofayili yezonyango kunye neziphumo zeklinikhi ze-geldanamycin derivatives luthembisa ukuphucula amaqhinga okunyanga umhlaza kunye neziphumo kwixesha elizayo.